
Sign up to save your podcasts
Or
Shadd Dales and Anthony Varrell sit down with two of the biggest names in the cannabis industry: Beena Goldenberg, CEO of Organigram (NASDAQ: OGI), and Boris Jordan, Executive Chairman of Curaleaf (OTCQX: CURLF).Beena breaks down what’s behind Organigram’s record-setting quarter — with revenue hitting $65.6 million, fueled by the Motif Labs acquisition and strong growth overseas. She also dives into their push into the hemp-derived beverage market, what’s next for their partnership with BAT, and how they’re positioning themselves in both Canada and Europe as the global cannabis landscape evolves.Then, we go stateside with Boris Jordan. He unpacks Curaleaf’s Q1 performance — $310 million in revenue and improved margins — and gives us a real look at how the company is navigating market headwinds. We also get his take on the booming hemp THC space, and he doesn’t hold back on New York’s $15 million licensing fee, calling it a major hurdle for growth.It’s a timely conversation as investors weigh the impact of federal rescheduling, the rise of hemp, and shifting political winds under the Trump administration.0:00:00 Intro0:00:24 Cannabis Industry Overview0:01:27 Hockey Playoffs Beena Goldenburg Interview0:03:07 Organigram Earnings Report0:08:00 London Facility Strategy0:11:07 International Market Expansion0:14:38 Market Share Defense0:17:13 Hemp-Derived THC Beverages0:19:28 Political Landscape and Excise TaxBoris Jordan Interview0:22:14 - Curaleaf's Q1 2025 earnings0:27:10 - Florida market & brand developments0:29:52 - Marketing campaign ideas0:30:42 - Curaleaf's International market expansion0:32:14 - EU GMP certified Vape product development0:39:38 - Debt restructuring and refinancing plans0:42:50 - Hemp Store conversion in Florida0:56:32 - New York Market Challenges1:07:15 - Hemp-driven Federal legalization1:11:18 - Overall industry outlook#CannabisStocks #HempTHC #Curaleaf #Organigram #CannabisInvesting #CannabisFinance #MarijuanaRescheduling #CannabisPolicy #CannabisETFs #TrumpAdministrationWant to see last week's recap? • Weekly Recap: Cannabis Reform, Resche... Want to see more Cannabis Reform videos? • 5 Hidden Risks of Investing in Cannab... • What Federal Cannabis Legalization Wi... • Legal Expert Explains Marijuana Resch... • Trump’s DEA Nominee Signals Cannabis ... Want to be updated on Cannabis, Small Cap, AI, and Crypto? Subscribe to our Daily Baked in Newsletter!https://newsletter.thedalesreport.com...Find us as well on Facebook, Twitter, Instagram, LinkedIn and on the Web:Facebook: / thedalesreport Twitter: / thedalesreport Instagram: / dalesreport LinkedIn: / the-dales-report Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, please get in touch with us at:[email protected] views on the Trade To Black podcast and the guests on this podcast are purely opinions. You should not treat any opinions expressed by us or our guests as investment advice. The views on this podcast are solely intended to be informational and are not investment advice. Please go to our website for a full list of disclosures and details of any client relationship we have. https://thedalesreport.com/website-te...
5
77 ratings
Shadd Dales and Anthony Varrell sit down with two of the biggest names in the cannabis industry: Beena Goldenberg, CEO of Organigram (NASDAQ: OGI), and Boris Jordan, Executive Chairman of Curaleaf (OTCQX: CURLF).Beena breaks down what’s behind Organigram’s record-setting quarter — with revenue hitting $65.6 million, fueled by the Motif Labs acquisition and strong growth overseas. She also dives into their push into the hemp-derived beverage market, what’s next for their partnership with BAT, and how they’re positioning themselves in both Canada and Europe as the global cannabis landscape evolves.Then, we go stateside with Boris Jordan. He unpacks Curaleaf’s Q1 performance — $310 million in revenue and improved margins — and gives us a real look at how the company is navigating market headwinds. We also get his take on the booming hemp THC space, and he doesn’t hold back on New York’s $15 million licensing fee, calling it a major hurdle for growth.It’s a timely conversation as investors weigh the impact of federal rescheduling, the rise of hemp, and shifting political winds under the Trump administration.0:00:00 Intro0:00:24 Cannabis Industry Overview0:01:27 Hockey Playoffs Beena Goldenburg Interview0:03:07 Organigram Earnings Report0:08:00 London Facility Strategy0:11:07 International Market Expansion0:14:38 Market Share Defense0:17:13 Hemp-Derived THC Beverages0:19:28 Political Landscape and Excise TaxBoris Jordan Interview0:22:14 - Curaleaf's Q1 2025 earnings0:27:10 - Florida market & brand developments0:29:52 - Marketing campaign ideas0:30:42 - Curaleaf's International market expansion0:32:14 - EU GMP certified Vape product development0:39:38 - Debt restructuring and refinancing plans0:42:50 - Hemp Store conversion in Florida0:56:32 - New York Market Challenges1:07:15 - Hemp-driven Federal legalization1:11:18 - Overall industry outlook#CannabisStocks #HempTHC #Curaleaf #Organigram #CannabisInvesting #CannabisFinance #MarijuanaRescheduling #CannabisPolicy #CannabisETFs #TrumpAdministrationWant to see last week's recap? • Weekly Recap: Cannabis Reform, Resche... Want to see more Cannabis Reform videos? • 5 Hidden Risks of Investing in Cannab... • What Federal Cannabis Legalization Wi... • Legal Expert Explains Marijuana Resch... • Trump’s DEA Nominee Signals Cannabis ... Want to be updated on Cannabis, Small Cap, AI, and Crypto? Subscribe to our Daily Baked in Newsletter!https://newsletter.thedalesreport.com...Find us as well on Facebook, Twitter, Instagram, LinkedIn and on the Web:Facebook: / thedalesreport Twitter: / thedalesreport Instagram: / dalesreport LinkedIn: / the-dales-report Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, please get in touch with us at:[email protected] views on the Trade To Black podcast and the guests on this podcast are purely opinions. You should not treat any opinions expressed by us or our guests as investment advice. The views on this podcast are solely intended to be informational and are not investment advice. Please go to our website for a full list of disclosures and details of any client relationship we have. https://thedalesreport.com/website-te...
39 Listeners
3,685 Listeners
93 Listeners
1,839 Listeners
205 Listeners
67 Listeners
5,244 Listeners
406 Listeners
104 Listeners
28,354 Listeners
8,543 Listeners
119 Listeners
7 Listeners
12 Listeners
958 Listeners